UroGen UGN-102 Impresses On Durability Data

 
• By Jessica Merrill

The company announced strong durability data at 12 months for patients with low-grade intermediate risk non-muscle invasive bladder cancer treated with UGN-102. 

target
UroGen durability data for UGN-102 hit the mark • Source: Shutterstock

More from Clinical Trials

More from R&D